Opportunistic infection


An opportunistic infection is an infection that occurs most commonly in individuals with an immunodeficiency disorder and acts more severely on those with a weakened immune system. These types of infections are considered serious and can be caused by a variety of pathogens including viruses, bacteria, fungi, and parasites. Under normal conditions, such as in humans with uncompromised immune systems, an opportunistic infection would be less likely to cause significant harm and would typically result in a mild infection or no effect at all. These opportunistic infections can stem from a variety of sources, such as a weakened immune system, when being treated with immunosuppressive drugs, when a microbiome is altered, or when integumentary barriers are breached. Opportunistic infections can contribute to antimicrobial resistance in an individual making these infections more severe. Some pathogens that cause these infections possess intrinsic resistance to many antibiotics while others acquire resistance over time through mutations or horizontal gene transfer. Many of these pathogens, such as the bacterium Clostridioides difficile, can be present in hosts with uncompromised immune systems without generating any symptoms, and can, in some cases, act as commensals until the balance of the immune system is disrupted. With C. diff and many other pathogens, the overuse or misuse of antibiotics can cause the disruption of normal microbiota and lead to an opportunistic infection caused by antibiotic resistant pathogens. In some cases, opportunistic infections can be labeled as a hospital-acquired infection due to individuals contracting them within a healthcare/hospital setting. In terms of history, there is not one individual that can be attributed for discovering opportunistic infections. Over time and through medical advancement, there have been many scientists that have contributed to the study and treatment options for patients affected by these infections.

Types of opportunistic infections

Opportunistic infections can be caused by a wide variety of different types of pathogens. These infections can be caused by viral, bacterial, fungal, as well as parasitic pathogens.
A partial list of opportunistic pathogens and their associated effects are as follows:

Bacteria

Human immunodeficiency virus is a virus that targets the CD4 cells within the body's immune system and causes HIV disease or HIV/AIDS. CD4 counts within a non-affected immune system would range anywhere from 500-1500 cells per cubic millimeter of blood, while an affected immune system would show cell counts below 200. HIV infection can lead to progressively worsening immunodeficiency, a condition ideal for the development of opportunistic infection. As HIV worsens over time, the term AIDS, or acquired immunodeficiency syndrome has been used to describe the condition and extensive damage to the immune system as well as the onset and susceptibility to other illnesses. The onset of AIDS leads to respiratory and central nervous system opportunistic infections, including but not limited to pneumonia, tuberculosis and meningitis. Kaposi's sarcoma, a virally associated cancer, and non-Hodgkin's lymphoma are two types of cancers that are generally defined as AIDS malignancies. As immune function declines and HIV-infection progresses to AIDS, individuals are at an increased risk of opportunistic infections that their immune systems are no longer capable of responding properly to. Because of this, opportunistic infections are a leading cause of HIV/AIDS-related deaths.

Causes

is characterized by the absence of or the disruption in components of the immune system such as white blood cells. These disruptions cause a decrease in immune function and result in an overall reduction of immunity against pathogens.
They can be caused by a variety of factors, including:
  • Pre-existing conditions such as
  • * HIV/AIDS infection
  • * Systemic Lupus Erythematosus
  • * Rheumatoid arthritis
  • * Multiple Sclerosis and the treatments associated with it
  • Other causes include:
  • * Undergoing organ transplant with the use of immunosuppressant agents
  • * Receiving chemotherapy and other immunosuppressant drugs to combat cancer
  • * Malnutrition
  • * Genetic predisposition
  • * Skin damage- cuts, burns, etc.
  • * Antibiotic treatment or the misuse of antibiotics leading to disruption of the normal microbiome, thus allowing some microorganisms to outcompete others and become pathogenic
  • * Medical procedures such as surgeries, endoscopies, implants, and catheterization
  • * Pregnancy due to increase susceptibility and hormonal changes
  • * Aging
  • * Leukopenia
  • * The lack of or the disruption of normal vaginal microbiota

    Prevention

Since opportunistic infections can cause severe disease, much emphasis is placed on measures to prevent infection. Such a strategy usually includes restoration of the immune system as soon as possible, avoiding exposures to infectious agents, and using antimicrobial medications directed against specific infections.

Restoration of immune system

  • In patients with HIV, starting antiretroviral therapy is recommended for restoration of the immune system and reducing the incidence rate of opportunistic infections
  • In patients undergoing chemotherapy, completion of, and recovery from treatment is the primary method for immune system restoration and to prevent infection occurrence. In a select subset of high-risk patients, granulocyte colony stimulating factors can be used to aid immune system recovery and infection prevention.

    Avoidance of infectious exposure

  • Ensure poultry is cooked to 165 °F. Beef and pork cuts should reach an internal temperature of 145 °F. Ground meat should be cooked to 160 °F. Ensure juice, and dairy products are labeled as pasteurized. Eggs should be cooked until both yolks and whites are firm.
  • Avoid oral exposure to feces.
  • Ensure proper steps such as regular handwashing, and use of PPE are followed for the care of farm animals who are sick, specifically those experiencing diarrhea.
  • Ensure proper handling and handwashing with cat feces : source of Toxoplasma gondii, Bartonella spp.
  • Avoid soil/dust in areas where there is known Histoplasma capsulatum present. If it cannot be avoided in an environment, ensure PPE is being used.
  • Ensure reptiles and amphibians, their live food, and their waste are being handled properly and wash hands regularly after handling to prevent transmission of pathogens such as Salmonella.
  • Avoid unprotected sexual intercourse with individuals that have sexually transmitted infections.

    Prophylactic medications

Individuals at higher risk for opportunistic infections are often prescribed prophylactic medication to prevent an infection from occurring. A person's risk level for developing an opportunistic infection is approximated using the person's CD4 T-cell count and other indicators such as current medical treatments, age, and lifestyle choices. The table below provides information regarding the treatment management of common opportunistic infections.
Opportunistic infectionsIndication for prophylactic medicationsPreferred agentWhen to discontinue agentSecondary prophylactic/maintenance agent
Mycobacterium tuberculosisUpon diagnosis of HIV, any positive screening test, or prior medical history of Mycobacterium tuberculosis.
These current agents' doses/frequency will discontinue after two months. Depending on clinical presentation, maintenance agents will continue for at least four more months.
  • Rifampicin, isoniazid, and pyridoxine
  • Pneumocystis jiroveciCD4 count is less than 200 cells/mm3 or less than 14%. The person has documented medical history of recurrent oropharyngeal candidiasis.
  • Trimethoprim-sulfamethoxazole
  • This current agent doses/frequency will discontinue after 21 days. Secondary prophylactic agent dose/frequency will continue until the CD4 count is above 200 cells/mm3 and the HIV viral load is undetectable for at least three months while taking antiretroviral therapy.
  • Trimethoprim-sulfamethoxazole
  • Toxoplasma gondiiCD4 count is less than 100 cells/mm3 or less than 14%, and the person has a positive serology for Toxoplasma gondii.
  • Trimethoprim-sulfamethoxazole
  • This agent will discontinue after six weeks. Secondary prophylactic medications will continue until the CD4 count is above 200 cells/mm3 and HIV viral load is undetectable for at least six months while taking antiretroviral therapy.
  • Sulfadiazine, pyrimethamine, and folinic acid
  • Mycobacterium avium complex diseaseCD4 count is less than 50 cells/mm3 and has a detectable viral load while taking antiretroviral therapy.
  • Clarithromycin and ethambutol
  • Rifabutin may be added depending on clinical presentation.
  • These agent will discontinue after 12 months only if the person does not have any symptoms that will be concerning for persistent Mycobacterium avium complex disease and their CD4 count is above 100 cells/mm3, and while their HIV viral load is undetectable for at least six months while taking antiretroviral therapy.N/A

    Alternative prevention

    Alternative agents can be used instead of the preferred agents. These alternative agents may be used due to an individual's allergies, availability, or clinical presentation. The alternative agents are listed in the table below.
    Opportunistic infectionsAlternative agent
    Mycobacterium tuberculosis
    Pneumocystis jiroveci
  • Dapsone
  • Atovaquone
  • Pentamidine
  • Toxoplasma gondii
  • Dapsone, pyrimethamine, and folinic acid
  • Atovaquone, pyrimethamine, and folinic acid
  • Mycobacterium avium complex disease
  • Azithromycin and ethambutol
  • Treatment

    Due to the prevention techniques used with HIV patients, such as prophylactic medications, opportunistic infections in HIV patients have decreased in number over the past few decades. In some circumstances, where individuals are not aware they have HIV and they develop an opportunistic infection, they may be prescribed antivirals, antibiotics, or antifungals. After the infection has cleared, and to prevent it from coming back, they may be recommended to stay on that medication as well as it being coupled with another medication to ensure drug efficiency.